Close Menu

NEW YORK – The latest version of the National Comprehensive Cancer Network's breast cancer clinical practice guidelines has included Biotheranostics' gene expression assay Breast Cancer Index as a tool for predicting whether patients will benefit from extended, adjuvant endocrine therapy. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.